Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma plc (VRNA) | 1,115,352 | 1,115,352 | 0 | 16,128 | 32,089 | 12.29% | +15,961 |
| Bicara Therapeutics Inc. (BCAX) | 0 | 568,919 | +568,919 | 0 | 14,490 | 5.55% | +14,490 |
| Biomea Fusion Inc (BMEA)(BMEA) | 798,757 | 798,757 | 0 | 3,594 | 8,067 | 3.09% | +4,473 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 5,507 | 7,803 | 2.99% | +2,297 |
| Tectonic Therapeutic Inc (TECX)(TECX) | 84,148 | 84,148 | 0 | 1,386 | 2,550 | 0.98% | +1,164 |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,068,125 | 0 | 153,706 | 154,494 | 59.18% | +789 |
| Compass Pathways Plc (CMPS)(CMPS) | 964,500 | 964,500 | 0 | 5,826 | 6,076 | 2.33% | +251 |
| CalciMedica, Inc. (CALC)(CALC) | 521,114 | 521,114 | 0 | 2,064 | 2,309 | 0.88% | +245 |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | 1,338 | 1,506 | 0.58% | +168 |
| Aclaris Therapeutics Inc (ACRS)(ACRS) | 434,455 | 434,455 | 0 | 478 | 500 | 0.19% | +22 |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | 3,046 | 2,984 | 1.14% | -63 |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | 157 | 66 | 0.03% | -91 |
| Marker Therapeutics, Inc. (MRKR)(MRKR) | 314,286 | 314,286 | 0 | 1,707 | 886 | 0.34% | -820 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,025,000 | 1,025,000 | 0 | 21,043 | 19,731 | 7.56% | -1,312 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,541,009 | 0 | 7,420 | 5,819 | 2.23% | -1,601 |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | 7,654 | 1,701 | 0.65% | -5,953 |